z-logo
open-access-imgOpen Access
Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4+T-Cell Clones
Author(s) -
Philip J. Norris,
Marina Sumaroka,
Christian Berthou,
Howell F. Moffett,
Steven L. Boswell,
Tam Hong Nguyen,
Yuri Sykulev,
Bruce D. Walker,
Eric Rosenberg
Publication year - 2001
Publication title -
journal of virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.617
H-Index - 292
eISSN - 1070-6321
pISSN - 0022-538X
DOI - 10.1128/jvi.75.20.9771-9779.2001
Subject(s) - biology , epitope , cytolysis , t cell , antigen , microbiology and biotechnology , virology , cytotoxic t cell , immune system , immunology , biochemistry , in vitro
Mounting evidence suggests that human immunodeficiency virus type 1 (HIV-1) Gag-specific T helper cells contribute to effective antiviral control, but their functional characteristics and the precise epitopes targeted by this response remain to be defined. In this study, we generated CD4(+) T-cell clones specific for Gag from HIV-1-infected persons with vigorous Gag-specific responses detectable in peripheral blood mononuclear cells. Multiple peptides containing T helper epitopes were identified, including a minimal peptide, VHAGPIAG (amino acids 218 to 226), in the cyclophilin binding domain of Gag. Peptide recognition by all clones examined induced cell proliferation, gamma interferon (IFN-gamma) secretion, and cytolytic activity. Cytolysis was abrogated by concanamycin A and EGTA but not brefeldin A or anti-Fas antibody, implying a perforin-mediated mechanism of cell lysis. Additionally, serine esterase release into the extracellular medium, a marker for cytolytic granules, was demonstrated in an antigen-specific, dose-dependent fashion. These data indicate that T helper cells can target multiple regions of the p24 Gag protein and suggest that cytolytic activity may be a component of the antiviral effect of these cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here